Oral leukoplakia: A clinicopathological review

Oral Oncology

Volumn 33, Issue 5, 1997, Pages 291-301

  Van Der Waal, I ^a   Schepman, K P ^a   Van Der Meij, E H ^a   Smeele, L E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Epithelial dysplasia; Oral leukoplakia; Precancerous lesion

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; BETA CAROTENE; BLEOMYCIN; FENRETINIDE; RETINOID; RETINOL;

ADULT; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CHEILITIS; CIGARETTE SMOKING; CONJUNCTIVITIS; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOUTH CANCER; PHOTOPHOBIA; PRECANCER; PRIORITY JOURNAL; REVIEW; TOPICAL DRUG ADMINISTRATION;

EID: 0031424204     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(97)00002-X     Document Type: Article

References (139)

1. Axéll, T., Pindborg, J. J., Smith, C. J., Waal van der, I. and an International Collaborative Group on Oral White Lesions, Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21, 1994. Journal of Oral Pathology and Medicine, 1996, 25, 49-54.
2. Axéll, T., Holmstrup, P., Kramer, I. R. H., Pindborg, J. J. Shear, M., International seminar on oral leukoplakia and associated lesions related to tobacco habits. Community Dental and Oral Epidemiology, 1984, 12, 145-154.
3. Kramer, I. R. H., Lucas, R. B., Pindborg, J. J., Sobin, L. H. WHO Collaborating Centre for Oral Precancerous Lesions, Definition of leukopakia and related lesions: an aid to studies on oral precancer. Oral Surgery, Oral Medicine, Oral Pathology, 1978, 46, 518-539.
4. Hogewind, W. F. C. and Waal van der, I., Leukoplakia of the labial commissure. British Journal of Oral Maxillofacial Surgery, 1988, 26, 133-140.
5. Greenspan, D., Greenspan, J. S., Conant, M., Petersen, V., Silverman, S. Jr and Souza de, Y., Oral "hairy" leucoplakia in male homosexuals: evidence of association with both papilloma virus and a herpes group virus. Lancet, 1984, 13, 831-834.
6. EC Clearinghouse on oral problems related to HIV infection and WHO Collaborating Centre on oral manifestations of the immunodeficiency virus. Classification and diagnostic criteria for oral lesions in HIV infection. Journal of Oral Pathology and Medicine, 1993, 22, 289-291.
7. Waal van der, I., Letter to the Editor. Greenspan lesion is a better term than oral "hairy" leukoplakia. Journal of Oral Pathology and Medicine, 1996, 25, 144.
8. Mehta F. S. and Hammer J. E. Tobacco-related oral mucosal lesions and conditions in India. A guide for dental students, dentists, and physicians. Basic Dental Research Unit, Tata Institute of Fundamental Research, Bombay, 1993.
9. Idris, A. M., Warnakulasuriya, K. A. A. S., Ibrahim, Y. E., Nielsen, R., Cooper, D. and Johnson, N. W., Toombak-associated oral mucosal lesions in Sudanese show a low prevalence of epithelial dysplasia. Journal of Oral Pathology and Medicine, 1996, 25, 239-244.
10. Larsson, Å, Axéll, T. and Andersson, G., Reversibility of snuff dipper's lesion in Swedish moist snuff users: a clinical and histological follow-up study. Journal of Oral Pathology and Medicine, 1991, 20, 258-264.
11. Kaugars, G. E., Riley, W. T., Brandt, R. B., Burns, J. C. and Svirsky, J. A., The prevalence of oral lesions in smokeless tobacco users and an evaluation of risk factors. Cancer, 1992, 70, 2579-2595.
12. Gupta, P. C., A study of dose-response relationship between tobacco habits and oral leukoplakia. British Journal of Cancer, 1984, 50, 527-531.
13. Roed-Petersen, B., Effect on oral leukoplakia of reducing or increasing tobacco smoking. Acta Dermatolvener, 1981, 62, 164-167.
14. World Health Organization. Report from a meeting of investigators on the histological definition of precancerous lesions, 1973. CAN/731, Geneva.
15. Gupta, P. C., Mehta, F. S., Daftary, D. K., et al., Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dental and Oral Epidemiology, 1980, 8, 287-333.
16. Silverman, S., Bhargava, K., Mani, N. J., Smith, L. W. and Malaowalla, A. M., Malignant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat, India. Cancer, 1976, 38, 1790-1795.
17. Pindborg, J. J., Renstrup, G., Jøst, O. and Roed-Petersen, B., Studies in oral leukoplakia: a preliminary report on the period of prevalence of malignant transformation in leukoplakia based on a follow-up study of 248 patients. JADA, 1968, 76, 767-771.
18. Bánóczy, J. and Sugar, L., Longitudinal studies in oral leukoplakias. Journal of Oral Pathology, 1972, 1, 265-272.
19. Silverman, S., Gorsky, M. and Lozada, F., Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer, 1984, 53, 563-568.
20. Lind, P. O., Malignant transformation in oral leukoplakia. Scandinavian Journal of Dental Research, 1987, 95, 449-455.
21. Tischendorf, L. and Giehler, U., Studien zur Dignität der Leukoplakie von Mundschleimhaut und Lippen. Deutsche Zeitschrift für Mund-, Kiefer-, und Gesichtschirurgie, 1990, 14, 301-305.
22. Dunsche, A., Kreusch, Th and Sauer, M., Die Leukoplakie der Mundschleimhaut - eine retrospektive Studie an 161 Patienten. Deutsch Zahnärztliche Zeitschrift, 1992, 47, 869-871.
23. Frerich, B., Bschorer, R., Gehrke, G., Gärtner, H. V. and Schwenzer, N., Maligne Transformation oraler Leukoplakien. Eine retrospektieve klinishche und zellproliferationskinetische Studie. Dtsch Zahnärztl Z, 1992, 47, 836-839.
24. Gundlach, K. K. H., Wieviele Plattenepithelkarzinome der Mundhöhle sind aus Leukoplakien entstanden? Deutsche Zeitschrift für Mund-, Kiefer-, und Gesichtschirugie, 1992, 16, 109-111.
25. Axéll, T., Occurrence of leukoplakia and some other white lesions among 20,333 adult Swedish people. Community Dental and Oral Epidemiology, 1987, 15, 46-51.
26. Gupta, P. C., Leukoplakia and incidence of oral cancer. Journal of Oral Pathology and Medicine, 1989, 18, 17.
27. Axéll, T., A prevalence study of oral mucosal lesions in an adult Swedish population. Odontologist Revy, 1976, 27(suppl. 36), 1976.
28. Waldron, C. A. and Shafer, W. G., Leukoplakia revisited. A clinicopathologic study of 3256 oral leukoplakias. Cancer, 1975, 36, 1386-1392.
29. Gupta, P. C., Epidemiologic study of the association between alcohol habits and oral leukoplakia. Community Dental and Oral Epidemiology, 1984, 12, 47-50.
30. Evstifeeva, T. V. and Zaridze, D. G., Nass use, cigarette smoking, alcohol consumption and risk of oral and oesophageal precancer. Oral Oncology, European Journal of Cancer, 1992, 28B, 29-35.
31. Kulasegaram, R., Downer, M. C., Jullien, J. A., Zakrzewska, J. M. and Speight, P. M., Case-control study of oral dysplasia and risk habits among patients of a dental hospital. Oral Oncology, European Journal of Cancer, 1995, 31B, 227-231.
32. Blot, W. J., Winn, D. M. and Fraumeni, J. F., Oral cancer and mouthwash. Journal of the National Cancer Institute, 1983, 70, 251-253.
33. Kabat, G. C., Hubert, J. R. and Wynder, E. L., Risk factors for oral cancer in women. Cancer Research, 1989, 49, 2803-2806.
34. Kramer, I. R. H., Precancerous conditions of the oral mucosa. A computer-aided study. Annals of the Royal College of Surgeons, England, 1969, 45, 340-356.
35. Krogh, P., Hald, B. and Holmstrup, P., Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis, 1987, 8, 1543-1548.
36. Field, E. A., Field, J. K. and Martin, M. V., Does Candida have a role in oral epithelial neoplasia? Journal of Medical and Veterinary Mycology, 1989, 27, 277-294.
37. Hornstein, O. P. and Gräßel, R., Häufigkeit und prognostische Bedeutung der Candida-Besiedelung oraler Leukoplakien. Deutsche Zeitschrift für Mund-, Kiefer-, und Gesichtschirurgie, 1992, 16, 112-116.
38. Miller, C. S. and White, D. K., Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma. A retrospective review of the literature. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology Endod, 1996, 82, 57-68.
39. Palefsky, J. M., Silverman, S., Abdel-Salaam, M., Daniels, T. E. and Greenspan, J. S., Association between proliferative verrucous leukoplakia and infection with human papilloma-virus type 16. Journal of Oral Pathology and Medicine, 1995, 24, 193-197.
40. Ramaswamy, G., Rao, V. R., Kumaraswamy, S. V. and Anantha, N., Serum vitamin's status in oral leucoplakias - a preliminary study. Oral Oncology, European Journal of Cancer, 1996, 32B, 120-122.
41. Johnson, N. W., Ranasinghe, A. W. and Warnakulasuriya, K. A. A. S., Potentially malignant lesions and conditions of the mouth and oropharynx: natural history - cellular and molecular markers of risk. European Journal of Cancer Prevention, 1993, 2(suppl. 2), 31-51.
42. Baric, J. M., Alman, J. E., Feldman, R. S. and Chauncey, H. H., Influence of cigarette, pipe, and cigar smoking, removable partial dentures, and age on oral leukoplakia. Oral Surgery, Oral Medicine, Oral Pathology, 1982, 54, 424-429.
43. Bánóczy, J. and Sugár, L., Progressive and regressive changes in Hungarian oral leukoplakias in the course of longitudinal studies. Community Dental and Oral Epidemiology, 1975, 3, 194-197.
44. Sciubba, J. J., Oral leukoplakia. Critical Review of Oral Biology and Medicine, 1995, 6, 147-160.
45. Gupta, P. C., Bhonsle, R. B., Murti, P. R., Daftary, D. L., Mehta, F. S. and Pindborg, J. J., An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer, 1989, 63, 2247-2252.
46. Hansen, L. S., Olson, J. A. and Silverman, S., Proliferative verrucous leukoplakia. Oral Surgery, Oral Medicine, Oral Pathology, 1985, 60, 285-298.
47. Shear, M. and Pindborg, J. J., Verrucous hyperplasia of the oral mucosa. Cancer, 1980, 46, 1855-1862.
48. Zakrzewska, J. M., Lopes, V., Speight, P. M. and Hopper, C., Proliferative verrucous leukoplakia. A report of ten cases. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology Endod, 1996, 82, 396-401.
49. Miller, R. L., Simms, B. W. and Gould, A. R., Toluidine blue staining for detecting of oral premalignant lesions and carcinomas. Journal of Oral Pathology, 1988, 17, 73-78.
50. Epstein, J. B., Scully, C. and Spinelli, J. J., Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. Journal of Oral Pathology and Medicine, 1992, 21, 160-163.
51. Barrellier, P., Babin, E., Louis, M. Y. and Meunier-Guttin, A., Utilisation du bleu de toluidine dans le diagnostic des lésions néoplasiques de la cavité buccale. Revue de Stomatologie et Chirurgie Maxillofaciale, 1993, 94, 51-54.
52. Warnakulasuriya, K. A. A. S. and Johnson, N. W., Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. Journal of Oral Pathology and Medicine, 1996, 25, 97-103.
53. Fornatora, M., Cale, Jones A., Kerpel, S. and Freedman, P., Human papillomavirus-associated oral epithelial dysplasia (koilocytic dysplasia). An entity of unknown biologie potential. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology Endod, 1996, 82, 47-56.
54. Krutchkoff, D. J. and Eisenberg, E., Lichenoid dysplasia: a distinct histopathologic entity. Oral Surgery, Oral Medicine, Oral Pathology, 1985, 60, 308-315.
55. Pindborg, J. J., Reibel, J., Roed-Petersen, B. and Mehta, F. S., Tobacco-induced changes in oral leukoplakic epithelium. Cancer, 1980, 45, 2330-2336.
56. Daniels, T. E., Hansen, L. S., Greenspan, J. S., et al., Histopathology of smokeless tobacco lesions in professional baseball players. Association with different types of tobacco. Oral Surgery, Oral Medicine, Oral Pathology, 1992, 73, 720-725.
57. Murrah, V. A. and Batsakis, J. G., Proliferative verrucous leukoplakia and verrucous hyperplasia. Annals of Otology Rhinology and Laryngology, 1994, 103, 660-663.
58. Slootweg, P. J. and Müller, H., Verrucous hyperplasia or verrucous carcinoma. An analysis of 27 patients. Journal of Maxillofacial Surgery, 1983, 11, 13-19.
59. Vesper, M., Schmelzle, R., Ritter-Kröhn, R. and Günzl, H-J., Vergleichende Untersuchung histologisch gesicherter Leukoplakien im Cavum oris. Deutsche Zahnärztliche Zeitschrift, 1992, 47, 867-869.
60. Pindborg, J. J., Reibel, J. and Holmstrup, P., Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. Journal of Oral Pathology, 1985, 14, 698-708.
61. Karabalut, A., Reibel, J., Therkildsen, M. H., Praetorius, F., Neilsen, H. W. and Dabelsteen, E., Observer variability in the histologic assessment of oral premalignant lesions. Journal of Oral Pathology and Medicine, 1995, 24, 198-200.
62. Lumerman, H., Freedman, P. and Kerpel, S., Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology Endod, 1995, 79, 321-329.
63. Abbey, L. M., Kaugars, G. E., Gunsolley, J. C., et al., Intraexaminer and interexaminer reliability in the diagnosis of oral epithelal dysplasia. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology Endod, 1995, 80, 188-191.
64. Burkhardt, A., Advanced methods in the evaluation of premalignant lesions and carcinomas of the oral mucosa. Journal of Oral Pathology, 1985, 14, 751-778.
65. Waldron, C. A. and Shafter, W. G., Leukoplakia revisted. A clinicoplathologic study of 3256 oral leukoplakias. Cancer, 1975, 36, 1386-1392.
66. Crissman, J. D. and Zarbo, R. J., Dysplasia, in situ carcinoma, and progression to invasive squamous cell carcinoma of the upper aerodigestive tract. American Journal of Surgery and Pathology, 1989, 13(suppl), 5-16.
67. Su, L., Morgan, P. R. and Lane, E. B., Keratin 14 and 19 expression in normal, dysplastic and malignant oral epithelia. A study using in situ hybridization and immunohistochemistry. Journal of Oral Pathology and Medicine, 1996, 25, 293-301.
68. Kannan, R., Bijur, G. N., Mallery, S. R., et al., Transforming growth factor-alpha overexpression in proliferative verrucous leukoplakia and oral squamous cell carcinoma. An immunohistochemical study. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology Endod, 1996, 82, 69-74.
69. Johnson, N. W., Warnakulasuriya, S. and Tavassoli, M., Hereditary and environmental risk factors; clinical and laboratory risk markers for head and neck, especially oral, cancer and precancer. European Journal of Cancer Prevention, 1996, 5, 5-17.
70. Johnson N. E. (ed.). Risk Markers for Oral Diseases, Vol. 2. Oral Cancer: Detection of Patients and Lesions at Risk. Cambridge University Press, Cambridge, 1991.
71. Abdel-Salam, M., Mayall, B. H., Chew, K., Silverman, S. Greenspan, J. S., Which oral white lesions will become malignant? An image cytometric study. Oral Surgery Oral Medicine Oral Pathology, 1990, 69, 345-350.
72. Mao, L., Lee, J. S., Fan, Y. H., et al., Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nature Medicine, 1996, 2, 682-685.
73. Heyden, A., Huitfeld, H. S., Koppang, H. S., Thrane, P. S., Bryne, M. and Brandtzaeg, P., Cytokeratins as epithelial differentiation markers in premalignant and malignant oral lesions. Journal of Oral Pathology and Medicine, 1992, 21, 7-11.
74. Kinoshita, Y., Inoue, S., Honma, Y. and Shimura, K., Diagnostic significance of nuclear DNA content and nuclear area in oral hyperplasia, dysplasia, and carcinoma. Journal of Oral Maxillofacial Surgery, 1992, 50, 728-733.
75. Eversole, L. R. and Sapp, J. P., c-myc oncoprotein expression in oral precancerous and early cancerous lesions. Oral Oncology, European Journal of Cancer, 1993, 28B, 131-135.
76. Kahn, M. A., Mincer, H. H., Dockter, M. E. and Hermann-Petrin, J. M., Comparing flow cytometric analysis and nucleolar organizer region enumeration in archival oral premalignant lesions. Journal of Oral Pathology and Medicine, 1993, 22, 257-262.
77. Scully, C. and Burkhardt, A., Tissue markers of potentially malignant human oral epithelial lesions. Journal of Oral Pathology and Medicine, 1993, 22, 246-256.
78. Steinbeck, R. G., Moege, J., Heselmeyer, K. M., et al., DNA content and PCNA immunoreactivity in oral precancerous and cancerous lesions. Oral Oncology, European Journal of Cancer, 1993, 29B, 279-284.
79. Warnakulasuriya, K. A. A. S. and Johnson, N. W., Nucleolar organiser region (NOR) distribution as a diagnostic marker in oral keratosis, dysplasia and squamous cell carcinoma. Journal of Oral Pathology and Medicine, 1993, 22, 77-81.
80. Zöller, J., Flentje, M., Sinn, P. and Born, I. A., "Nukleolar Organizer Region" und "Ki-67" als zellkinetische parameter für oral dysplasien und plattenepithelkarzinome. Deutsche Zeitschrift für Mund-, Kiefer-, und Gesichtschirurgie, 1993, 17, 185-190.
81. Saiton, K., Yamashita, T., Notani, K-I., et al., Flow cytometric analysis of nuclear DNA content in oral leukoplakia: relation to clinicopathologic findings. International Journal of Oral Maxillofacial Surgery, 1995, 24, 44-47.
82. Robinson, P. A., Markham, A. F., Schalkwijk, J. and High, A. S., Increased elafin expression in cystic, dysplastic and neoplastic oral tissues. Journal of Oral Pathology and Medicine, 1996, 25, 135-139.
83. Velden van der, L-A., Schaafsma, H. E., Manni, J. J., Ramaekers, F. C. S. and Kuijpers, W., Cytokeratin expression in normal and (pre)malignant head and neck epithelia: an overview. Head and Neck, 1993, 15, 133-146.
84. Shirasuma, K., Hayashido, Y., Sugiyama, M., Yoshioka, H. Matsuya, T., Immuno-histochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy. Virchows Archiv A. Pathologische Anatomie, 1991, 418, 349-353.
85. High, A. S., Robinson, P. A. and Klein, C. E., Increased expression of a 38kd cell-surface glycoprotein MH99 (KS 1/4) in oral mucosal dysplasia. Journal of Oral Pathology and Medicine, 1996, 25, 10-13.
86. Bryne, M., Reibel, J., Mandel, U. and Dabelsteen, E., Expression of mucin type carbohydrates may supplement histologic diagnosis in oral premalignant lesions. Journal of Oral Pathology and Medicine, 1991, 20, 120-125.
87. Coltrera, M. D., Zarbo, R. J., Sakr, W. A. and Gown, A. M., Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. American Journal of Pathology, 1992, 141, 817-825.
88. Schliephake, H., Eckardt, A., Gaida-Martin, C. and Pytlik, C., PCNA/Cyclin-Antikörper als Proliferationsmarker bei Mundschleimhauterkrankungen. Deutsche Zahnärztliche Zeitschrift, 1992, 47, 845-848.
89. Tsuji, T., Shrestha, P., Yamada, K., et al., Proliferating cell nuclear antigen in malignant and pre-malignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study. Virchows Archiv A. Pathologische Anatomie, 1992, 420, 377-383.
90. Huang, W. Y-F., Coltrera, M., Schubert, M., Morton, T. and Truelove, E., Histopathological evaluation of proliferating cell nuclear antigen (PC10) in oral epithelial hyperplasia and premalignant lesions. Oral Surgery, Oral Medicine, Oral Pathology, 1994, 78, 748-754.
91. Girod, S. C., Kruger, G. and Pape, H-D., p53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa. International Journal of Oral Maxillofacial Surgery, 1993, 22, 285-288.
92. Nishioka, H., Hiasa, Y., Hayashi, I., Kitahori, Y., Konishi, N. Sugimara, M., Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings. Oncology, 1993, 50, 426-429.
93. Girod, S. C., Fischer, U., Knüfermann, R., Krämer, Ch and Krüger, G. R. F., p53-Mutationen bei Leukoplakien, Lichen planus und Karzinomen der Mundschleimhaut. Deutsche Zeitschrift für Mund-, Kiefer-, und Gesichtschirurgie, 1994, 18, 250-253.
94. Regezi, J. A., Zarbo, R. J., Regev, E., Pisanty, S., Silverman, S. and Gazit, D., p53 protein expression in sequential biopsies of oral dysplasia and in situ carcinomas. Journal of Oral Pathology and Medicine, 1995, 24, 18-22.
95. Matsuda, H., Konishi, N., Hiasa, Y., et al., Alterations of p16/CDKN2, p53 and ras genes in oral squamous cell cacinomas and premalignant lesions. Journal of Oral Pathology and Medicine, 1996, 25, 232-238.
96. Kusama, K., Okutsu, S., Takeda, A., et al., p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma. Journal of Pathology, 1996, 178, 415-421.
97. Sugerman, P. B., Savage, N. W., Xu, L. J., Walsh, L. J. and Seymour, G. J., Heat shock protein expression in oral epithelial dysplasia and squamous cell carcinoma. Oral Oncology, European Journal of Cancer, 1995, 31B, 63-67.
98. Pillai, K. R., Kannan, S., Koshy, P., et al., Scanning electron microscopy of different types of oral leukoplakia: comparison with normal and malignant oral mucosa. Oral Oncology, European Journal of Cancer, 1994, 30B, 400-404.
99. Neilsen, H., Norrild, B., Vedtofte, P., Praetorius, F., Reibel, J. and Holmstrup, P., Human papillomavirus in oral premalignant lesions. Oral Oncology, European Journal of Cancer, 1996, 32B, 264-270.
100. Kahn, M. A., Dockter, M. E. and Hermann-Petrin, J. M., Proliferative verrucous leukoplakia. Four cases with flow cytometric analysis. Oral Surgery, Oral Medicine, Oral Pathology, 1994, 78, 469-475.
101. Pindborg, J. J., Daftary, D. K. and Mehta, F. S., A follow-up study of sixty-one oral dysplastic precancerous lesions in Indian villagers. Oral Surgery, Oral Medicine, Oral Pathology, 1977, 43, 383-390.
102. Kramer, I. R. H., El-Labban, N. and Lee, K. W., The clinical features and risk of malignant transformation in sublingual keratosis. British Dental Journal, 1978, 144, 171-180.
103. Shibuya, H., Amagasa, T., Seto, K-I., Ishibashi, K., Horiuchi, J-I. and Suzuki, S., Leukoplakia-associated multiple carcinomas in patients with tongue carcinoma. Cancer, 1986, 57, 843-846.
104. Bouquot, J. E., Weiland, L. H. and Kurland, L. T., Leukoplakia and carcinoma in situ synchronously associated with oral/oropharyngeal carcinoma in Rochester, Minn., 1935-1984. Oral Surgery, Oral Medicine, Oral Pathology, 1988, 65, 199-207.
105. Grant, W. E., Hopper, C., Speight, P. M., Macrobert, A. J. Bown, S. G., Photodynamic therapy of malignant and premalignant lesions in patient with 'field cancerization' of the oral cavity. Journal of Laryngology and Otology, 1993, 107, 1140-1145.
106. Gregory, G. F., Hopper, C., Fan, K., Grant, W. E., Bown, S. G. and Speight, P. M., Photodynamic therapy and lip vermilion dysplasia: a pilot study. Oral Oncology, European Journal of Cancer, 1995, 31B, 346-347.
107. Fan, K. F. M., Hopper, C., Speight, P. M., Buonaccorsi, G., MacRobert, A. J. and Bown, S. G., Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesion of the oral cavity. Cancer, 1996, 78, 1374-1383.
108. Nauta, J. M., Van Leengoed, H. L. L. M., Star, W. N., Roodenburg, J. L. N., Witjes, M. J. H. and Vermey, A., Photodynamic therapy of oral cancer. A review of basic mechanism and clinical applications. European Journal of Oral Science, 1996, 104, 69-81.
109. Vedtofte, P., Holmstrup, P., Hjørting-Hansen, E. and Pindborg, J. J., Surgical treatment of premalignant lesions of the oral mucosa. International Journal of Oral Maxillofacial Surgery, 1987, 16, 656-664.
110. Chiesa, F., Boracchi, P., Tradati, N., et al., Risk of preneoplastic and neoplastic events in operated oral leukoplakias. Oral Oncology, European Journal of Cancer, 1993, 29B, 23-28.
111. Browne, R. M. and Potts, A. J. C., Dysplasia in salivary gland ducts in sublingual leukoplakia and erythroplakia. Oral Surgery. Oral Medicine, Oral Pathology, 1986, 62, 44-49.
112. Chiesa, F., Tradati, N., Sala, L., et al., Follow-up of oral leukoplakia after carbon dioxide laser surgery. Archives Otolaryngology Head Neck Surgery, 1990, 116, 177-180.
113. Roodenburg, J. L. N., Panders, A. K. and Vermey, A., Carbon dioxide laser surgery of oral leukoplakia. Oral Surgery, Oral Medicine, Oral Pathology, 1991, 71, 670-674.
114. Stich, H. F., Hornby, A. P., Mathew, B., Sankaranarayanan, R. and Nair, M. K., Response of oral leukoplakia to the administration of vitamin A. Cancer Letters, 1988, 40, 93-101.
115. Girod, S. C. and Pfahl, M., Retinoid actions and implications for prevention and therapy of oral cancer. International Journal of Oral Maxillofacial Surgery, 1996, 25, 69-73.
116. Toma, S., Mangiante, P. E., Margarino, G., Nicolo, G. and Palumbo, R., Progressive 13-cis-retinoid acid dosage in the treatment of oral leukoplakia. Oral Oncology, European Journal of Cancer, 1992, 28B, 121-123.
117. Lippman, S. M., Batsakis, J. G., Tom, B. B., et al., Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. New England Journal of Medicine, 1993, 328, 15-20.
118. 1 3. American Journal of Clinical Nutrition, 1991, 53, 298S-304S.
119. Krishnaswamy, K., Prasad, M. P. R., Krishna, T. P., Annapurna, V. V. and Reddy, G. A., A case study of nutrient intervention of oral precancerous lesions in India. Oral Oncology, European Journal of Cancer, 1995, 31B, 41-48.
120. Kaugers, G. E., Silverman, S., Lovas, J. G. L., et al., A clinical trial of antioxidant supplement in the treatment of oral leukoplakia. Oral Surgery, Oral Medicine, Oral Pathology, 1994, 78, 462-468.
121. Kaugers, G. E., Silverman, S., Lovas, J. G. L., Thompson, J. S., Bandt, R. B. and Singh, V. N., Use of antioxidant supplements in the treatment of human oral leukoplakia. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology Endod, 1996, 81, 5-14.
122. Garewal, H. A., Meyskens, F. L., Killen, D., et al., Response of oral leukoplakia to beta-carotene. Journal of Clinical Oncology, 1990, 8, 1715-1720.
123. Garewal, H., Chemoprevention of oral cancer: beta-carotene and vitamin E in leukoplakia. European Journal of Cancer Prevention, 1994, 3, 101-107.
124. Hammersley, N., Ferguson, M. M. and Rennie, J. S., Topical bleomycin in the treatment of oral leukoplakia: a pilot study. British Journal of Oral Maxillofacial Surgery, 1985, 23, 251-258.
125. Wong, F., Epstein, J. and Millner, A., Treatment of oral leukoplakia with topical bleomycin. A pilot study. Cancer, 1989, 64, 361-365.
126. Epstein, J. B., Wong, F. L., Millner, A. and Le, N. D., Topical bleomycin treatment of oral leukoplakia: a randomized double-blind clinical trial. Head and Neck, 1994, 16, 539-544.
127. Malmström, M., Hietanen, J., Sane, J. and Sysmäläinen, M., Topical treatment of oral leukoplakia with bleomycin. British Journal of Oral Maxillofacial Surgery, 1988, 26, 491-498.
128. Benner, S. E., Winn, R. J., Lippman, S. M., et al., Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study. Journal of National Cancer Institute, 1993, 85, 44-47.
129. Benner, S. E., Wargovich, M. J., Lippman, S. M., et al., Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia. Cancer Epidemiology, Biomarkers & Prevention, 1994, 3, 73-76.
130. Chiesa, F., Tradati, N., Marazza, M., et al., Prevention of local relapse and new localisations of oral leukoplakias with the synthetic retiniod fenretinide (4-HPR). Preliminary results. Oral Oncology, European Journal of Cancer, 1992, 28B, 97-102.
131. Tradati, N., Chiesa, F., Rossi, N., et al., Successful topical treatment of oral lichen planus and leukoplakia with fenretinide (4-HPR). Cancer Letters, 1994, 76, 109-111.
132. Scully, C., Oral precancer: preventive and medical approaches to management. Oral Oncology, European Journal of Cancer, 1995, 31B, 16-26.
133. Bouquot, J. E. and Whitaker, S. B., Oral leukoplakia - rationale for diagnosis and prognosis of its clinical subtypes or "phases". Quintessence International, 1994, 25, 133-140.
134. Marley, J. J., Cowan, C. G., Lamey, P-J., Linden, G. J., Johnson, N. W. and Warnakulasuriya, K. A. A. S., Management of potentially malignant oral mucosal lesions by consultant UK oral and maxillofacial surgeons. British Journal of Oral Maxillofacial Surgery, 1996, 34, 28-36.
135. Gupta, P. C., Mehta, F. S., Pindborg, J. J., et al., Intervention study for primary prevention of oral cancer among 36000 Indian tobacco users. Lancet, 1986, May 31, 1235-1241.
136. Gupta, P. C., Mehta, F. S., Pindborg, J. J., et al., Primary prevention trial of oral cancer in India: a 10-year follow-up study. Journal of Oral Pathology and Medicine, 1992, 21, 433-439.
137. Tomar, S. L., Husten, C. G. and Manley, M. W., Do dentists and physicians advise tobacco users to quit? Journal of the American Dental Association, 1996, 127, 259-265.
138. Speight, P. M., Downer, M. C. and Zakrzewska, J. Jr (eds), Screening for oral cancer and precancer. Report of a UK Working Groups. Community Dental Health, 1993, 10(suppl. 1), 1-89.
139. Schepman, K. P. and Waal van der, I., A proposal for a classification and staging system for oral leukoplakia: a preliminary study. Oral Oncology, European Journal of Cancer, 1995, 31B, 396-398.